Spots Global Cancer Trial Database for cd19.car t cells
Every month we try and update this database with for cd19.car t cells cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR | NCT03676504 | Acute Lymphobla... Acute Lymphobla... Chronic Lymphoc... Diffuse Large B... Follicular Lymp... Mantle Cell Lym... | CD19.CAR T Cell... Fludarabine Cyclophosphamid... | 3 Years - | University Hospital Heidelberg | |
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR | NCT03676504 | Acute Lymphobla... Acute Lymphobla... Chronic Lymphoc... Diffuse Large B... Follicular Lymp... Mantle Cell Lym... | CD19.CAR T Cell... Fludarabine Cyclophosphamid... | 3 Years - | University Hospital Heidelberg |